SCHEMBL7123602

SCHEMBL7123602

CC(=O)Nc1ccc2nc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)sc2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DYRK1A Q13627 1/20 0.67
▸ RAB9A P51151 7/20 0.64
▸ MAPT P10636 6/20 0.64
▸ THRB P10828 2/20 0.64
▸ POLB P06746 2/20 0.64
▸ LMNA P02545 1/20 0.64
▸ KMT2A Q03164 6/20 0.62
▸ MEN1 O00255 4/20 0.62
▸ ALDH1A1 P00352 3/20 0.61
▸ NPC1 O15118 4/20 0.60
▸ CACNA1B Q00975 1/20 0.60
▸ APBA1 Q02410 1/20 0.60
▸ MCL1 Q07820 2/20 0.59
▸ HPGD P15428 1/20 0.59
▸ HTT P42858 1/20 0.59
▸ NPSR1 Q6W5P4 1/20 0.59
▸ MMP13 P45452 1/20 0.58
▸ CXCR2 P25025 1/20 0.57
▸ HSD17B10 Q99714 1/20 0.57
▸ STAT1 P42224 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7125923 0.91 DYRK1A (0.57) DYRK1ARAB9AMAPTTHRBPOLB
SCHEMBL7129461 0.91 DYRK1A (0.70) DYRK1ARAB9AMAPTPOLBLMNA
SCHEMBL7125975 0.89 MAPT (0.62) DYRK1ARAB9AMAPTTHRBPOLB
SCHEMBL7124202 0.88 DYRK1A (0.54) DYRK1ARAB9AMAPTTHRBPOLB
SCHEMBL7162058 0.88 DYRK1A (0.64) DYRK1ARAB9AMAPTPOLBLMNA
SCHEMBL7127487 0.88 MMP13 (0.74) DYRK1ARAB9AMAPTPOLBLMNA
SCHEMBL7124297 0.87 DYRK1A (0.61) DYRK1ARAB9AMAPTPOLBLMNA
SCHEMBL7119606 0.86 MAPT (0.61) DYRK1ARAB9AMAPTPOLBLMNA
SCHEMBL7127519 0.85 SCD (0.73) DYRK1ARAB9AMAPTPOLBLMNA
SCHEMBL5731624 0.84 MAPT (0.69) DYRK1ARAB9AMAPTLMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 — — US claimed
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 — — CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 — — US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD DYRK1A 3783/4885RAB9A 1179/4885MAPT 4391/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback